Type(s) of hormonal therapy-Anti-androgens Posts on Medivizor
Navigation Menu

Type(s) of hormonal therapy-Anti-androgens Posts on Medivizor

Evaluating the effects of olaparib on pain and the health-related quality of life in patients with metastatic castration-resistant prostate cancer.

Evaluating the effects of olaparib on pain and the health-related quality of life in patients with metastatic castration-resistant prostate cancer.

Posted by on Aug 8, 2022 in Prostate cancer | 0 comments

In a nutshell This study evaluated the effects of olaparib (Lynparza) on pain and the health-related quality of life (HR-QoL) in patients with metastatic castration-resistant prostate cancer (mCRPC) with mutations (genetic abnormalities) in DNA repair genes. The data showed that treatment with olaparib was associated with a reduction in pain and...

Read More

Comparing two hormone therapy drugs in men with advanced, non-metastatic prostate cancer

Posted by on Nov 17, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to compare two hormone therapies, gonadotropin-releasing hormone (GnRH) agonists and anti-androgen therapy (AA) in men with advanced, non-metastatic prostate cancer. This study found that the two therapies have similar outcomes, but by starting with AA treatment may reduce side effects associated with GnRH...

Read More

Looking for patients with prostate cancer who have had a rise in PSA after prostate removal surgery

Looking for patients with prostate cancer who have had a rise in PSA after prostate removal surgery

Posted by on Aug 31, 2018 in Prostate cancer | 0 comments

In a nutshell This trial is examining the effectiveness of different hormone therapy regimes for patients whose prostate specific antigen (PSA; a protein elevated in prostate cancer) levels rise after prostate removing surgery. The main outcome to be measured will be the change in PSA levels.   The details The best standard treatment...

Read More

Searching for men undergoing androgen deprivation therapy to participate in diet and exercise program

Posted by on Aug 31, 2018 in Prostate cancer | 0 comments

In a nutshell This trial is examining the effectiveness of diet and exercise during ADT treatment for men with prostate cancer. The main outcome to be measured will be the change in body mass index (BMI, a measure of body fat that takes height and weight into account). This study is being conducted in Los Angeles and Kansas City,...

Read More

Fibrinogen – a new predictor in prostate cancer

Fibrinogen – a new predictor in prostate cancer

Posted by on Dec 15, 2014 in Prostate cancer | 0 comments

In a nutshell The authors evaluated whether fibrinogen could be used to determine cancer survival in prostate cancer.  Some background Fibrinogen is a very important protein that clots blood inside the body. It has previously been used to determine the metastatic potential (likelihood that the cancer cells will spread) of lung cancers and...

Read More